If you liked this article you might like

Valeant Could be Worth 30% More If It Can Continue to Execute Various Initiatives
Paulson Ups Valeant Stake; Activist Investor Targets Nestle -- ICYMI Monday
Valeant Higher on Paulson Stake Increase; ImmunoGen Pops; Seattle Genetics Perplexes: Biotech Movers
These Stocks Are Changing Course